Pfizer could make $26 BILLION from COVID-19 vaccine boosters as the US approves third dose for all adults over 65 as well as those with pre-existing conditions and high-risk...

The CDC endorsed third Pfizer shots for adults 65 and older and adults 18 and over with pre-existing conditions and high-risk jobs. Guidance on Moderna and J&J boosters is expected…